Cat. No. 1965
Chemical Name: (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexa
Biological ActivityHMG-CoA reductase inhibitor; decreases levels of low density lipoprotein. Has multiple biological effects including bone formation stimulation, inhibition of smooth muscle cell proliferation and migration, and anticancer and anti-inflammatory activity. Inactive lactone prodrug of simvastatin hydroxy acid, naturally bioactivated in vivo following oral administration.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Kaushal et al (2003) Potential anticancer effects of statins: fact or fiction? Endothelium 10 49. PMID: 12699077.
Reinoso et al (2002) Preclinical pharmacokinetics of statins. Methods Find.Exp.Clin.Pharmacol. 24 593. PMID: 12616706.
Garrett et al (2001) Statins and bone formation. Curr.Pharm.Des. 7 715. PMID: 11405194.
White (1999) Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation. J.Clin.Pharmacol. 39 111. PMID: 11563401.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Simvastatin from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Simvastatin, supplier, HMG-CoA, reductase, inhibitors, inhibits, Reductases, Tocris Bioscience, HMG-CoA Reductase Inhibitor products